ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

OPK Opko Health Inc

1.2998
-0.0402 (-3.00%)
2024年6月8日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Opko Health Inc OPK NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0402 -3.00% 1.2998 06:00:59
始値 安値 高値 終値 前日終値
1.34 1.28 1.34 1.29 1.34
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/3123:48GLOBEOPKO Health to Participate in the Jefferies Global..
2024/5/0805:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0805:07EDGAR2Form 8-K - Current report
2024/5/0805:05GLOBEOPKO Health Reports First Quarter 2024 Business Highlights..
2024/5/0321:00GLOBEOPKO Health to Report First Quarter 2024 Financial Results..
2024/3/2821:00PRNUSLabcorp Announces Acquisition of Select Assets of..
2024/3/2021:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
2024/3/0806:02EDGAR2Form ARS - Annual Report to Security Holders
2024/3/0522:52GLOBEAIDS Clinical Trial Group Presents Results from Phase 1..
2024/3/0206:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
2024/2/2823:31PRNUSNextPlat Opens OPKO Health-Branded Storefront on Alibaba's..
2024/2/2806:07EDGAR2Form 8-K - Current report
2024/2/2806:05GLOBEOPKO Health Reports Fourth Quarter 2023 Business Highlights..
2024/2/2306:05GLOBEOPKO Health to Report Fourth Quarter 2023 Financial Results..
2024/2/1706:53EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/2/1006:07EDGAR2Form 8-K - Current report
2024/2/0522:09PRNUSNextPlat Receives Initial Approvals to Launch OPKO..
2024/1/3005:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2506:15EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/1/2506:00EDGAR2Form 8-K - Current report
2024/1/1807:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1107:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1007:09EDGAR2Form 8-K - Current report
2024/1/1006:05GLOBEOPKO Health Announces Closing of Private Offering of $230..
2024/1/0823:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0822:00GLOBEOPKO Health to Present at the 42nd Annual J.P. Morgan..
2024/1/0607:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0603:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0602:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0521:00EDGAR2Form 8-K - Current report
2024/1/0513:31GLOBEOPKO Health Announces Pricing of Private Offering of $200..
2024/1/0407:05GLOBEOPKO Health Announces Private Offering of Convertible Senior..
2023/11/2821:00PRNUSBioReference Health and Prognos Health Collaborate to..
2023/11/1322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0720:45PRNUSBioReference® Signs On as the First Laboratory to Use..
2023/11/0706:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0706:06EDGAR2Form 8-K - Current report
2023/11/0706:05GLOBEOPKO Health Reports Third Quarter 2023 Business Highlights..
2023/11/0223:00GLOBENew Clinical Data on OPKO Health’s RAYALDEE® (ER..
2023/11/0105:08EDGAR2Form 8-K/A - Current report: [Amend]
2023/10/3121:00GLOBEOPKO Health to Report Third Quarter 2023 Financial Results..
2023/10/2605:25GLOBEOPKO Health to Present New Clinical Data on Rayaldee (ER..
2023/9/2906:10DJNModeX Therapeutics Awarded Contract to Address Public Health..
2023/9/2905:09EDGAR2Form 8-K - Current report
2023/9/2905:08GLOBEModeX Therapeutics Secures BARDA Contract to Develop Novel..
2023/9/1221:30GLOBEEntera Bio Announces Collaboration with OPKO Biologics to..
2023/8/0405:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:07EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock